Setipiprant for androgenetic alopecia in males: Results from a randomized, double-blind, placebo-controlled phase 2a trial
Clinical, Cosmetic and Investigational Dermatology | Oct 21, 2021
A 10-year retrospective cohort study of ruxolitinib and association with non-melanoma skin cancer in polycythemia vera and myelofibrosis patients
Journal of the American Academy of Dermatology | Oct 14, 2021
A pooled analysis of randomized, controlled, phase 3 trials investigating the efficacy and safety of a novel, fixed dose calcipotriene and betamethasone dipropionate cream for the topical treatment of plaque psoriasis
Journal of the European Academy of Dermatology and Venereology | Oct 14, 2021